S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94

Venus Concept (VERO) Stock Forecast, Price & News

+0.16 (+22.33%)
(As of 05/13/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
367,000 shs
Average Volume
221,850 shs
Market Capitalization
$54.80 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive VERO News and Ratings via Email

Sign-up to receive the latest news and ratings for Venus Concept and its competitors with MarketBeat's FREE daily newsletter.

Venus Concept logo

About Venus Concept

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.


Venus Concept (VERO) Set to Announce Earnings on Thursday
Venus Concept gains on strong outlook for 2022
Venus Concept Q4 2021 Earnings Preview
See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$105.62 million
Book Value
$0.77 per share


Net Income
$-23.01 million
Pretax Margin




Free Float
Market Cap
$54.80 million
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.02 out of 5 stars

Medical Sector

566th out of 1,403 stocks

Surgical & Medical Instruments Industry

68th out of 137 stocks

Analyst Opinion: 3.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Venus Concept (NASDAQ:VERO) Frequently Asked Questions

Is Venus Concept a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Venus Concept in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Venus Concept stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VERO, but not buy additional shares or sell existing shares.
View analyst ratings for Venus Concept
or view top-rated stocks.

When is Venus Concept's next earnings date?

Venus Concept is scheduled to release its next quarterly earnings announcement on Friday, August 12th 2022.
View our earnings forecast for Venus Concept

How were Venus Concept's earnings last quarter?

Venus Concept Inc. (NASDAQ:VERO) posted its quarterly earnings results on Monday, March, 28th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.04. The company earned $32.63 million during the quarter, compared to analysts' expectations of $32.50 million. Venus Concept had a negative trailing twelve-month return on equity of 70.42% and a negative net margin of 20.46%. During the same quarter last year, the firm posted ($0.22) EPS.
View Venus Concept's earnings history

What guidance has Venus Concept issued on next quarter's earnings?

Venus Concept issued an update on its FY 2022 earnings guidance on Thursday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $126.00 million-$130.00 million, compared to the consensus revenue estimate of $127.66 million.

What price target have analysts set for VERO?

1 analysts have issued 1 year price targets for Venus Concept's shares. Their forecasts range from $2.00 to $2.00. On average, they anticipate Venus Concept's stock price to reach $2.00 in the next year. This suggests a possible upside of 133.6% from the stock's current price.
View analysts' price targets for Venus Concept
or view top-rated stocks among Wall Street analysts.

Who are Venus Concept's key executives?
Venus Concept's management team includes the following people:
  • Mr. Domenic Serafino, CEO & Director (Age 61, Pay $763.48k) (LinkedIn Profile)
  • Mr. Domenic Della Penna, Chief Financial Officer (Age 61, Pay $497.29k)
  • Mr. Soeren Maor Sinay, Chief Operating Officer (Age 51)
  • Mr. Michael Mandarello, Head of Legal & Corp. Sec.
  • Ms. Melissa Kang, Exec. VP of Global Marketing & Product Management (Age 54)
  • Mr. Ross J. Portaro, Pres of Global Sales (LinkedIn Profile)
  • Ms. Anna Georgiadis, VP of Global HR (Age 51)
What other stocks do shareholders of Venus Concept own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Venus Concept investors own include Spectrum Pharmaceuticals (SPPI), CONSOL Energy (CEIX), Salesforce (CRM), Cisco Systems (CSCO), SCYNEXIS (SCYX), AzurRx BioPharma (AZRX), Boeing (BA), Interpace Biosciences (IDXG), Johnson & Johnson (JNJ) and Advanced Micro Devices (AMD).

What is Venus Concept's stock symbol?

Venus Concept trades on the NASDAQ under the ticker symbol "VERO."

Who are Venus Concept's major shareholders?

Venus Concept's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (1.75%), Dimensional Fund Advisors LP (0.18%), Bank of New York Mellon Corp (0.14%), Essex Investment Management Co. LLC (0.06%) and HighTower Advisors LLC (0.03%). Company insiders that own Venus Concept stock include Chad A Zaring, Domenic Serafino, Healthquest Partners Ii, LP, Keith J Sullivan, Ross Portaro, Sedco Capital Cayman Ltd and Yoni Iger.
View institutional ownership trends for Venus Concept

Which institutional investors are selling Venus Concept stock?

VERO stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP.
View insider buying and selling activity for Venus Concept
or view top insider-selling stocks.

Which institutional investors are buying Venus Concept stock?

VERO stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Essex Investment Management Co. LLC, Vanguard Group Inc., and HighTower Advisors LLC. Company insiders that have bought Venus Concept stock in the last two years include Chad A Zaring, Domenic Serafino, Healthquest Partners Ii, LP, Keith J Sullivan, Ross Portaro, and Yoni Iger.
View insider buying and selling activity for Venus Concept
or or view top insider-buying stocks.

How do I buy shares of Venus Concept?

Shares of VERO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Venus Concept's stock price today?

One share of VERO stock can currently be purchased for approximately $0.86.

How much money does Venus Concept make?

Venus Concept has a market capitalization of $54.80 million and generates $105.62 million in revenue each year. The company earns $-23.01 million in net income (profit) each year or ($0.38) on an earnings per share basis.

How many employees does Venus Concept have?

Venus Concept employs 407 workers across the globe.

What is Venus Concept's official website?

The official website for Venus Concept is www.venusconcept.com.

How can I contact Venus Concept?

Venus Concept's mailing address is 235 YORKLAND BLVD SUITE 900, TORONTO A6, M2J 4Y8. The company can be reached via phone at (888) 907-0115 or via email at [email protected].

This page was last updated on 5/16/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.